期刊文献+

2型糖尿病患者合并非酒精性脂肪性肝病危险因素分析 被引量:2

Risk factors for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
原文传递
导出
摘要 收集我院2007年1月至2008年4月内分泌科住院的2型糖尿病患者400例,男女各200例,经B超诊断为非酒精性脂肪性肝病(NAFLD)267例,无脂肪肝133例,比较两组问体重指数、腰臀比、空腹血糖、血脂、肝肾功能、超敏c反应蛋白(hsCRP)、尿微量白蛋白/肌酐(Alb/Cr)等指标,分析各因素与NAFLD的相关性。结果显示,男性NAFLD患者的年龄小于女性。NAFLD组体重指数(t=11.361,P=0.000)、腰围(t=9.771,P=0.000)、臀围(t=10.469,P=0.000)、甘油三酯(t=7.352,P=0.000)、hsCRP(t=2.242,P=0.026)均高于非NAFLD组,高密度脂蛋白显著低于非NAFLD组(t=-3.489,P=0.000);中心性肥胖组hsCRP显著高于非中心性肥胖组(t=0.266,P=0.045)。体重指数、甘油三酯与NAFLD独立正相关;男性患者腰围与NAFLD的发病独立相关,女性患者臀围与NAFLD的发病独立相关。提示2型糖尿病患者中NAFLD的发病与性别、中心性肥胖、血脂等代谢综合征相关因素密切相关。 Two hundred male and 200 female patients with type 2 diabetes mellitus admitted from January 2007 to April 2008 were enrolled in the study. Of them, 267 were diagnosed as non-alcoholic fatty liver disease (NAFLD) by altrasonography. The measurements included:body mass index (BMI), waist-tohip ratio ( WHR), fasting blood glucose (FBG) , ALT, AST, total bilirubin ( TBIL), cholesterol ( CHO ), triglyceride( TG), high density lipoprotein cholesterol ( HDL-C ) , low density lipoprotein cholesterol ( LDL- C) , serum creatinine (Cr) , supersensitive C-reactive protein ( hsCRP ) and urine albumin/creatinine. The relationship of above factors with NAFLD was determined. Our data showed that male NAFLD patients were in general younger than female. The BMI ( t = 11,361, P = 0. 000 ) , waist circumference ( t = 9. 771, P = 0. 000) , hip circumference (t = 10. 469, P =0. 000) ,TG(t =7. 352, P =0. 000) and hsCRP (t =2. 242, P = 0. 026) of NAFLD patients were significantly higher than those without NAFLD. The hsCRP of patients with central obesity was also significantly higher than those without central obesity ( t = 0. 266, P = 0. 045 ), BMI and TG were positively correlated with NAFLD. Waist circumference was an independent factor of NAFLD in male patients, same as hip circumference with NAFLD in female patients. In conclusion, gender, central obesity and dyslipidcmia may be risk factors for NAFLD in patients with type 2 diabetes mellitus.
作者 苏琳 刘玉兰
出处 《中华全科医师杂志》 2010年第1期47-49,共3页 Chinese Journal of General Practitioners
关键词 糖尿病 2型 非酒精性脂肪肝病 危险因素 Type 2 diabetes mellitus Non-alcoholic fatty liver disease Risk factors
  • 相关文献

参考文献7

二级参考文献25

  • 1曾民德.葡萄糖毒性、脂肪毒性与非酒精性脂肪性肝病[J].中华肝脏病杂志,2005,13(2):81-82. 被引量:64
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 3Anatol Panasiuk,Janusz Dzieciol,Bozena Panasiuk,Danuta Prokopowicz.Expression of p53,Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease[J].World Journal of Gastroenterology,2006,12(38):6198-6202. 被引量:48
  • 4Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 5Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 6Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 7Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 8Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 9Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 10Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.

共引文献619

同被引文献30

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华糖尿病杂志,2010,2(1). 被引量:522
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 3Valantinas J, Apanaviciene DA, Maroziene L, et al. The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania. Med Sci Monit, 2012,18(5 ) : PH57-62.
  • 4Barr J, Caballer i a J, Mart f nez-Arranz I, et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease protvession. J Proteome Res, 2012,11 (4) : 2521-2532.
  • 5Marks P,Williams R. Calorie and alcohol consumption in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol, 2012,24 ( 5 ) : 527-530.
  • 6Krupp D ,Johner SA, Kalhoff H, et al. Long-term dietary potential renal acid load during adolescence is prospectively associated with indices of nonalcoholic fatty liver disease in young women. J Nutr, 2012,142(2) :313-319.
  • 7Bonapace S, Perseghin G, Molon G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care, 2012,35 (2) : 389- 395.
  • 8Pagadala MR,Zein CO, Dasarathy S,et al. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Dig Dis Sci, 2012,57(2) :528-534.
  • 9Porepa L,Ray JG,Sanchez-Romeu P,et al. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ, 2010,182( 11 ) :E526-531.
  • 10Koller T, Kollerova J, Hlavaty T, et al. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol,2012,47(2) : 197-203.

引证文献2

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部